Ima-Press Publishing House 1
1. Analysis of the course of immune-mediated inflammatory rheumatic diseases after COVID-19: flare frequency and prognostic determinants
2. CLINICAL MANIFESTATIONS OF DAMAGE TO THE CARDIOVASCULAR SYSTEM AND PREDICTORS OF POOR PROGNOSIS OF TAKAYASU ARTERITIS IN KYRGYZ PATIENTS
3. Depletion-restitution therapy of autoimmune rheumatic diseases. Part 2. Perspectives on bispecific antibodies
4. Efficacy and safety of olokizumab in the treatment of rheumatoid arthritis in real-world clinical practice in Kazakhstan
5. Efficacy and safety of the biosimilar etanercept in the treatment of patients with rheumatoid arthritis and spondyloarthritis
6. Epidemiological, demographic, social, clinical features of manifestations of system red lupus in patients in Kazakhstan
7. Eurasian recommendations for the diagnosis and treatment of primary osteoarthritis (2025). League of Eurasian Rheumatologists (LEAR)
8. FEATURES OF CLINICAL MANIFESTATIONS, COURSE, OUTCOMES AND HEALTH RELATED QUALITY OF LIFE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN THE REPUBLIC OF KAZAKHSTAN
9. Forecasting index of unfavorable outcomes of systemic lupus erythematosus
10. Multimorbidity in osteoarthritis and pleiotropic effects of slow-acting symptomatic drugs. Resolution of the multidisciplinary International Expert Council
11. Objective assessment of the damaging effect of glucocorticoids (toxicity index) in patients with systemic lupus erythematosus
12. On the problem of differential diagnosis in the detection of antineutrophil cytoplasmic antibodies
13. RHEUMATOID ARTHRITIS AND POST-COVID-19 SYNDROME
14. Shared features of pathogenetic aspects, autoimmunity and pharmacotherapy in coronavirus infection (COVID-19) and immunoinflammatory rheumatic diseases
15. Steroid-sparing strategy for the treatment of vasculitis associated with antineutrophil cytoplasmic antibodies
16. Vasculitis mimics. Part 2. Large and medium vessel vasculitis mimickers: genetic vasculopathies. Mimickers of small vessel vasculitis
1